Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB) does about 191.88K shares in volume on a normal day but saw 379301 shares change hands in the recent trading day. The company now has a market cap of 29.01M USD. Its current market price is $2.02, marking an increase of 3.06% compared to the previous close of $1.96. The 52 week high reached by this stock is $1.98 whilst the lowest price level in 52 weeks is $0.42.
Chemomab Therapeutics Ltd ADR (CMMB) has a 20-day trading average at $1.28 and the current price is 2.03% off the 52-week high compared with 380.95% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.17 and its 200-day simple moving average is $0.82. If we look at the stock’s price movements over the week, volatility stands at 13.93%, which decreases to 12.17% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 84.11 to suggest the stock is overbought.
The consensus objective for the share price is $8.67, suggesting that the stock has a potential upside of 76.7% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 13, 2024 when Maxim Group initiated the stock to “Buy” and issued a price target of $4. Oppenheimer upgraded the stock to “Outperform” from Perform on May 06, 2024 at a price target of $6. ROTH MKM resumed its price target at $7.
The current price level is 64.03%, 76.38%, and 149.72% away from its SMA20, SMA50, and SMA200 respectively, with the CMMB price moving below the 50-day SMA on current market day. Chemomab Therapeutics Ltd ADR (CMMB) stock is up 44.29% over the week and 73.39% over the past month. Its price is 296.08% year-to-date and 81.98% over the past year.
To reach the target analysts have set, the stock logically needs to grow 76.7 percent from here.
The company has a return on investment of -147.03% and return on equity of -94.14%. The beta has a value of 0.48. Price to book ratio is 2.90.
